Synthetic peptide manufacturing turns a controlled molecular definition into a physical lineage through repeated chemistry, selective transformations, difficult separations, and quantity decisions. The final API must trace to sequence, stereochemistry, protecting groups, resin, amino-acid lots, cycles, fragments, fractions, pools, conjugates, analytical methods, and every loss or rework.
Seal represents that lineage directly. It does not force peptide manufacture into a generic recipe that knows only “reaction,” “purification,” and “release.”
The molecular definition is the manufacturing authority
Sequence, direction, amino-acid identity, chirality, non-natural residues, modifications, termini, disulfide pattern, conjugation site, salt or counterion, molecular formula and mass, structure, impurity strategy, specifications, methods, and lifecycle state form the approved product definition.
Structured positions support recipe generation, expected mass, material calculation, sequence-related impurity naming, and independent verification. A rendered sequence remains a view, not the sole source of truth.
Sequence versions are controlled independently of batches
Draft, reviewed, approved, effective, superseded, and retired definitions retain comparison, signatures, intended products, process applicability, and regulatory state. Changes highlight substitution, insertion, deletion, stereochemistry, protection, modification, and conjugation differences.
An active batch cannot resolve an unapproved molecular version. A change can assess in-process material and future campaigns separately.
Manufacturing strategy selects the right route
Solid-phase synthesis, liquid-phase synthesis, hybrid approaches, protected fragments, fragment condensation, recombinant inputs, late-stage conjugation, and product-specific transformations can use different configured paths.
The route defines intermediates, isolations, controls, holds, and impurity risks without losing common sequence and genealogy principles.
Recipe generation is deterministic and independently checked
The effective sequence, scale, resin loading, protection strategy, chemistry, and process version generate ordered cycles, materials, stoichiometry, parameters, expected consumption, washes, repeats, and equipment method.
Generator version, inputs, checksum, manual overrides, review, and approval remain visible. The batch instruction is reconciled with the molecular definition before execution.
Raw materials have residue- and operation-specific purpose
Protected amino acids, resin and linker, coupling reagents, bases, deprotection agents, scavengers, cleavage reagents, solvents, catalysts, buffers, conjugates, and membranes retain identity, grade, chirality, purity, water or other critical attributes, lot, status, storage, expiry, and open life.
Actual issue connects each lot to the residue, cycle, fragment, or transformation where used. A later supplier alert can find exact sequence positions and final containers exposed.
Synthesis captures cycle performance without copying the controller
The synthesizer or reactor system can remain authoritative for dense valve actions, flows, and signals. Seal records cycle identity, residue position, intended chemistry, material lots, key parameters, monitoring response, alarms, holds, repeats, deviations, source data, and acceptance.
A repeated coupling preserves the first attempt and its evidence. It cannot silently shift the remaining sequence or overwrite consumption.
Fragments retain independent identity before condensation
Each protected or partially deprotected fragment has molecular definition, source synthesis, terminal state, quantity, purity, container, storage, hold, tests, and disposition. Condensation records actual stoichiometry, activation, additions, conditions, yield, and resulting lineage.
Many-to-one convergence remains explicit. A fragment-specific concern can trace forward to every derived pool and API container.
Cleavage and deprotection create governed chemical states
Resin or support, reagent composition, time, temperature, mixing, washes, transfers, precipitation, recovery, and deprotection conditions remain connected to the synthesis lot. The crude product receives identity, quantity, concentration or solids basis, container, quality state, and hold.
Partial deprotection, staged cleavage, oxidation or folding, and product-specific quench paths retain their own transformations and controls.
Purification fractions are material, not rows in a report
Chromatography load, column, packing, resin cycle, mobile phases, gradient, detector signals, fractions, volumes, concentrations, purity, identity, impurity profile, containers, and status form one record.
Discarded, held, pooled, reprocessed, and investigation fractions remain in genealogy and mass balance. Chromatographic interval and source data stay linked to the physical container.
Pooling is a scientific decision with quantity consequences
The plan defines eligible fractions and preliminary criteria. Actual inclusion or exclusion records identity, purity, critical sequence impurities, concentration, volume, molar or mass contribution, rationale, reviewer, and recalculated pool state.
A pool amendment creates a versioned decision; it never edits the original selection after downstream processing begins.
Conjugation, cyclization, and folding preserve precursor lineage
Fatty-acid or other conjugation, linker activation, ligation, cyclization, disulfide formation, folding, quench, purification, and residual removal connect precursor lots, stoichiometry, conditions, samples, yields, and analytical evidence.
Positional isomers and incomplete reaction products remain tied to the exact molecular and process versions used to define them.
Desalting, counterion exchange, and concentration track chemical basis
Membrane, cassette, buffer, exchange cycles, conductivity, pH, concentration, volumes, solvent transition, counterion, yields, integrity, samples, and holds remain part of the lineage.
Quantity basis stays explicit: peptide free base, salt form, dry content, assay-corrected mass, net peptide content, or molar amount. Conversions retain formulas, units, source values, precision, and review.
Drying and final handling preserve physical state
Lyophilization, precipitation, filtration, drying, milling, sieving, subdivision, and packaging record equipment, recipes, containers, environment, exposure, conditions, samples, yields, and reconciliation.
Final containers retain identity, quantity basis, label, storage, sample withdrawals, status, use, shipment, and downstream drug-product genealogy.
Analytical control resolves peptide-specific impurities
Identity, assay, purity, sequence variants, deletion and insertion peptides, truncated species, epimers, racemization, deamidation, oxidation, aggregation, protecting-group residues, conjugate species, residual solvents, water, counterion, bioburden, and endotoxin attach to exact material states.
Methods retain sample preparation, molecular reference, instrument, raw data, integration or deconvolution, standards, impurity nomenclature, calculation, specification, and review.
Mass balance is chemistry-aware
The batch reconciles theoretical loading, resin substitution, amino-acid and reagent use, crude recovery, fragment quantities, fraction contributions, pool amount, samples, rework, waste, dry content, counterion, assay correction, final containers, and yield.
Mass, moles, peptide content, and solution volume are not treated as interchangeable. Unexplained differences open assessment before release.
Cleaning and campaign state reflect peptide carryover risk
Synthesizers, reactors, filters, columns, tanks, dryers, mills, and tools retain product-contact history, cleaning procedure, sequence- or potency-related residue target, analytical method, limits, results, and release.
Highly potent peptides, conjugates, and difficult-to-clean modifications can require dedicated or campaign controls. Actual equipment state gates the next product.
Release joins molecular, chemical, analytical, and quantity evidence
Disposition reconciles molecular version, route, generated recipe, material lots, cycle evidence, fragments, cleavage and deprotection, fractions, pool decisions, conjugation, final processing, analytical results, mass balance, holds, deviations, cleaning, containers, and stability obligations.
The EMA's guideline on development and manufacture of synthetic peptides addresses modality-specific manufacturing and control considerations. Seal organizes the executable evidence while manufacturer science and registered strategy remain authoritative.
Source systems retain automation and analytical depth
Synthesizer controls, chromatography data systems, mass spectrometry software, and process historians should retain native high-frequency or vendor-specific evidence. Seal references or captures what is needed to contextualize the batch and decision.
It owns molecular-
Where Seal is strongest
Seal is strongest when sequence and chemistry must remain connected to physical material and quality decisions. Because residue positions, material lots, cycles, fractions, pools, methods, impurities, and containers are related objects, forward and backward impact analysis is immediate.
A conventional MES can execute ordered steps; a LIMS can report purity. Seal's advantage is preserving why this batch, with these residue-level inputs and fraction decisions, became these released API containers.
Prove one sequence-to-container campaign
The first implementation should follow one modified peptide from approved sequence through generated recipe, resin and amino-acid issue, synthesis cycles, a repeated coupling, cleavage, purification fractions, pool amendment, conjugation, counterion exchange, drying, testing, mass balance, containers, cleaning, and release.
Include a wrong bottle-position scan, low coupling response, fragment failure, out-of-hold crude, borderline epimer fraction, amended pool, membrane-integrity failure, impurity integration change, assay-corrected discrepancy, and post-release amino-acid alert. The model is ready when each final container reconstructs every residue, transformation, fraction, and decision.
